Global CAR T-Cell Therapy Market Size, Share, Growth Analysis Report - Forecast 2034
CAR T-Cell Therapy Market By Product (Abecma (idecabtagene vicleucel), Breyanzi (lisocabtagene maraleucel), Carvykti (ciltacabtagene autoleucel), Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Yescarta (axicabtagene ciloleucel), Others), By Disease Indication (Leukemia, Lymphoma, Multiple Myeloma, Others), By End-Use (Hospitals, Cancer Treatment Centers), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 222 Report Code: ZMR-7458
Published Date: Jun-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 609.41 Million | USD 6594.52 Million | 26.89% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global CAR T-Cell Therapy Market Market, (2023 - 2030) (USD Million)
- 2.2 Global CAR T-Cell Therapy Market Market : snapshot
- Chapter 3. Global CAR T-Cell Therapy Market Market - Industry Analysis
- 3.1 CAR T-Cell Therapy Market Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 An increase in the incidences of cancer will trigger the global market growth trends over 2023-2030
- 3.3 Market Restraints
- 3.3.1. Side effects of CAR T-cell treatment can halt the growth of the global industry over the forecast period
- 3.4 Market Opportunities
- 3.4.1. Strategic partnerships & new product launches can create new opportunities for growth in the global market
- 3.5 Market Challenges
- 3.5.1. Demand for proficient manpower for executing CAR T-cell therapy can prove as a challenging factor in the growth of the global industry
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug Type
- 3.7.2 Market attractiveness analysis By Indication
- 3.7.3 Market attractiveness analysis By End-User
- Chapter 4. Global CAR T-Cell Therapy Market Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global CAR T-Cell Therapy Market Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global CAR T-Cell Therapy Market Market - Drug Type Analysis
- 5.1 Global CAR T-Cell Therapy Market Market overview: By Drug Type
- 5.1.1 Global CAR T-Cell Therapy Market Market share, By Drug Type, 2022 and 2030
- 5.2 Axicabtagene Ciloleucel
- 5.2.1 Global CAR T-Cell Therapy Market Market by Axicabtagene Ciloleucel, 2023 - 2030 (USD Million)
- 5.3 Brexucabtagene Autoleucel
- 5.3.1 Global CAR T-Cell Therapy Market Market by Brexucabtagene Autoleucel, 2023 - 2030 (USD Million)
- 5.4 Tisagenlecleucel
- 5.4.1 Global CAR T-Cell Therapy Market Market by Tisagenlecleucel, 2023 - 2030 (USD Million)
- 5.5 Others
- 5.5.1 Global CAR T-Cell Therapy Market Market by Others, 2023 - 2030 (USD Million)
- 5.1 Global CAR T-Cell Therapy Market Market overview: By Drug Type
- Chapter 6. Global CAR T-Cell Therapy Market Market - Indication Analysis
- 6.1 Global CAR T-Cell Therapy Market Market overview: By Indication
- 6.1.1 Global CAR T-Cell Therapy Market Market share, By Indication, 2022 and 2030
- 6.2 Chronic Lymphocytic Leukemia
- 6.2.1 Global CAR T-Cell Therapy Market Market by Chronic Lymphocytic Leukemia, 2023 - 2030 (USD Million)
- 6.3 Lymphoma
- 6.3.1 Global CAR T-Cell Therapy Market Market by Lymphoma, 2023 - 2030 (USD Million)
- 6.4 Multiple Myeloma
- 6.4.1 Global CAR T-Cell Therapy Market Market by Multiple Myeloma, 2023 - 2030 (USD Million)
- 6.5 Acute Lymphocytic Leukemia
- 6.5.1 Global CAR T-Cell Therapy Market Market by Acute Lymphocytic Leukemia, 2023 - 2030 (USD Million)
- 6.6 Others
- 6.6.1 Global CAR T-Cell Therapy Market Market by Others, 2023 - 2030 (USD Million)
- 6.1 Global CAR T-Cell Therapy Market Market overview: By Indication
- Chapter 7. Global CAR T-Cell Therapy Market Market - End-User Analysis
- 7.1 Global CAR T-Cell Therapy Market Market overview: By End-User
- 7.1.1 Global CAR T-Cell Therapy Market Market share, By End-User, 2022 and 2030
- 7.2 Hospitals
- 7.2.1 Global CAR T-Cell Therapy Market Market by Hospitals, 2023 - 2030 (USD Million)
- 7.3 Cancer Treatment Centers
- 7.3.1 Global CAR T-Cell Therapy Market Market by Cancer Treatment Centers, 2023 - 2030 (USD Million)
- 7.1 Global CAR T-Cell Therapy Market Market overview: By End-User
- Chapter 8. CAR T-Cell Therapy Market Market - Regional Analysis
- 8.1 Global CAR T-Cell Therapy Market Market Regional Overview
- 8.2 Global CAR T-Cell Therapy Market Market Share, by Region, 2022 & 2030 (USD Million)
- 8.3. North America
- 8.3.1 North America CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 8.3.1.1 North America CAR T-Cell Therapy Market Market, by Country, 2023 - 2030 (USD Million)
- 8.3.1 North America CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 8.4 North America CAR T-Cell Therapy Market Market, by Drug Type, 2023 - 2030
- 8.4.1 North America CAR T-Cell Therapy Market Market, by Drug Type, 2023 - 2030 (USD Million)
- 8.5 North America CAR T-Cell Therapy Market Market, by Indication, 2023 - 2030
- 8.5.1 North America CAR T-Cell Therapy Market Market, by Indication, 2023 - 2030 (USD Million)
- 8.6 North America CAR T-Cell Therapy Market Market, by End-User, 2023 - 2030
- 8.6.1 North America CAR T-Cell Therapy Market Market, by End-User, 2023 - 2030 (USD Million)
- 8.4. Europe
- 8.4.2 Europe CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 8.4.2.1 Europe CAR T-Cell Therapy Market Market, by Country, 2023 - 2030 (USD Million)
- 8.4.2 Europe CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 8.4 Europe CAR T-Cell Therapy Market Market, by Drug Type, 2023 - 2030
- 8.4.1 Europe CAR T-Cell Therapy Market Market, by Drug Type, 2023 - 2030 (USD Million)
- 8.5 Europe CAR T-Cell Therapy Market Market, by Indication, 2023 - 2030
- 8.5.1 Europe CAR T-Cell Therapy Market Market, by Indication, 2023 - 2030 (USD Million)
- 8.6 Europe CAR T-Cell Therapy Market Market, by End-User, 2023 - 2030
- 8.6.1 Europe CAR T-Cell Therapy Market Market, by End-User, 2023 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 8.5.3.1 Asia Pacific CAR T-Cell Therapy Market Market, by Country, 2023 - 2030 (USD Million)
- 8.5.3 Asia Pacific CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 8.4 Asia Pacific CAR T-Cell Therapy Market Market, by Drug Type, 2023 - 2030
- 8.4.1 Asia Pacific CAR T-Cell Therapy Market Market, by Drug Type, 2023 - 2030 (USD Million)
- 8.5 Asia Pacific CAR T-Cell Therapy Market Market, by Indication, 2023 - 2030
- 8.5.1 Asia Pacific CAR T-Cell Therapy Market Market, by Indication, 2023 - 2030 (USD Million)
- 8.6 Asia Pacific CAR T-Cell Therapy Market Market, by End-User, 2023 - 2030
- 8.6.1 Asia Pacific CAR T-Cell Therapy Market Market, by End-User, 2023 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.4 Latin America CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 8.6.4.1 Latin America CAR T-Cell Therapy Market Market, by Country, 2023 - 2030 (USD Million)
- 8.6.4 Latin America CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 8.4 Latin America CAR T-Cell Therapy Market Market, by Drug Type, 2023 - 2030
- 8.4.1 Latin America CAR T-Cell Therapy Market Market, by Drug Type, 2023 - 2030 (USD Million)
- 8.5 Latin America CAR T-Cell Therapy Market Market, by Indication, 2023 - 2030
- 8.5.1 Latin America CAR T-Cell Therapy Market Market, by Indication, 2023 - 2030 (USD Million)
- 8.6 Latin America CAR T-Cell Therapy Market Market, by End-User, 2023 - 2030
- 8.6.1 Latin America CAR T-Cell Therapy Market Market, by End-User, 2023 - 2030 (USD Million)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 8.7.5.1 The Middle-East and Africa CAR T-Cell Therapy Market Market, by Country, 2023 - 2030 (USD Million)
- 8.7.5 The Middle-East and Africa CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 8.4 The Middle-East and Africa CAR T-Cell Therapy Market Market, by Drug Type, 2023 - 2030
- 8.4.1 The Middle-East and Africa CAR T-Cell Therapy Market Market, by Drug Type, 2023 - 2030 (USD Million)
- 8.5 The Middle-East and Africa CAR T-Cell Therapy Market Market, by Indication, 2023 - 2030
- 8.5.1 The Middle-East and Africa CAR T-Cell Therapy Market Market, by Indication, 2023 - 2030 (USD Million)
- 8.6 The Middle-East and Africa CAR T-Cell Therapy Market Market, by End-User, 2023 - 2030
- 8.6.1 The Middle-East and Africa CAR T-Cell Therapy Market Market, by End-User, 2023 - 2030 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Intellia Therapeutics
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Pfizer Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Autolus Therapeutics
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 CARsgen Therapeutics Co. Ltd.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Juno Therapeutics Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Sorrento Therapeutics Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 bluebird bio Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 CELGENE CORPORATION
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Eureka Therapeutics Inc.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Avacta Life Sciences Ltd.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Calyxt Inc.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Celyad Oncology SA
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Fortress Biotech Inc.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Amgen Inc.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 IMMUNE THERAPEUTICS INC
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Caribou Biosciences Inc.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Gilead Sciences Inc.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Merck KGaA
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Novartis AG
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Alaunos Therapeutics Inc.
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 and Poseida Therapeutics Inc.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Intellia Therapeutics
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global CAR T-Cell Therapy Market Market attractiveness, By Drug Type
- 6. Global CAR T-Cell Therapy Market Market attractiveness, By Indication
- 7. Global CAR T-Cell Therapy Market Market attractiveness, By End-User
- 8. Global CAR T-Cell Therapy Market Market share by Drug Type, 2023 and 2030 (USD Million)
- 9. Global CAR T-Cell Therapy Market Market by Axicabtagene Ciloleucel, 2023 - 2030 (USD Million)
- 10. Global CAR T-Cell Therapy Market Market by Brexucabtagene Autoleucel, 2023 - 2030 (USD Million)
- 11. Global CAR T-Cell Therapy Market Market by Tisagenlecleucel, 2023 - 2030 (USD Million)
- 12. Global CAR T-Cell Therapy Market Market by Others, 2023 - 2030 (USD Million)
- 13. Global CAR T-Cell Therapy Market Market share by Indication, 2023 and 2030 (USD Million)
- 14. Global CAR T-Cell Therapy Market Market by Chronic Lymphocytic Leukemia, 2023 - 2030 (USD Million)
- 15. Global CAR T-Cell Therapy Market Market by Lymphoma, 2023 - 2030 (USD Million)
- 16. Global CAR T-Cell Therapy Market Market by Multiple Myeloma, 2023 - 2030 (USD Million)
- 17. Global CAR T-Cell Therapy Market Market by Acute Lymphocytic Leukemia, 2023 - 2030 (USD Million)
- 18. Global CAR T-Cell Therapy Market Market by Others, 2023 - 2030 (USD Million)
- 19. Global CAR T-Cell Therapy Market Market share by End-User, 2023 and 2030 (USD Million)
- 20. Global CAR T-Cell Therapy Market Market by Hospitals, 2023 - 2030 (USD Million)
- 21. Global CAR T-Cell Therapy Market Market by Cancer Treatment Centers, 2023 - 2030 (USD Million)
- 22. Global CAR T-Cell Therapy Market Market share, by Region, 2023 and 2030
- 23. North America CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 24. Europe CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 25. Asia Pacific CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 26. Latin America CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
- 27. The Middle-East and Africa CAR T-Cell Therapy Market Market, 2023 - 2030 (USD Million)
Table Of Tables
- 1. Global CAR T-Cell Therapy Market Market: Snapshot
- 2. Drivers of the CAR T-Cell Therapy Market Market: impact analysis
- 3. North America CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 4. North America CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 5. North America CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 6. U.S. CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 7. U.S. CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 8. U.S. CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 9. Canada CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 10. Canada CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 11. Canada CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 12. Europe CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 13. Europe CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 14. Europe CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 15. Germany CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 16. Germany CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 17. Germany CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 18. France CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 19. France CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 20. France CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 21. U.K. CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 22. U.K. CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 23. U.K. CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 24. Italy CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 25. Italy CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 26. Italy CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 27. Spain CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 28. Spain CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 29. Spain CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 30. Rest of Europe CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 31. Rest of Europe CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 32. Rest of Europe CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 33. Asia Pacific CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 34. Asia Pacific CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 35. Asia Pacific CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 36. China CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 37. China CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 38. China CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 39. Japan CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 40. Japan CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 41. Japan CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 42. India CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 43. India CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 44. India CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 45. South Korea CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 46. South Korea CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 47. South Korea CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 48. South-East Asia CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 49. South-East Asia CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 50. South-East Asia CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 51. Rest of Asia Pacific CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 52. Rest of Asia Pacific CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 53. Rest of Asia Pacific CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 54. Latin America CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 55. Latin America CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 56. Latin America CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 57. Brazil CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 58. Brazil CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 59. Brazil CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 60. Mexico CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 61. Mexico CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 62. Mexico CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 63. Rest of Latin America CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 64. Rest of Latin America CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 65. Rest of Latin America CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 66. The Middle-East and Africa CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 67. The Middle-East and Africa CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 68. The Middle-East and Africa CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 69. GCC Countries CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 70. GCC Countries CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 71. GCC Countries CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 72. South Africa CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 73. South Africa CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 74. South Africa CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
- 75. Rest of Middle-East Africa CAR T-Cell Therapy Market Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 76. Rest of Middle-East Africa CAR T-Cell Therapy Market Market revenue, By Indication, 2023 - 2030 (USD Million)
- 77. Rest of Middle-East Africa CAR T-Cell Therapy Market Market revenue, By End-User, 2023 - 2030 (USD Million)
Methodology
FrequentlyAsked Questions
CAR T-cell therapy is a kind of cancer immunotherapy that makes use of genetically modified immune cells referred to as T-cells for locating cancer tissues and destroying them. In addition to this, there are three steps involved in the CAR T-cell therapy that include collection of T-cells, infusing of CAR-T cells in the human body, and T-cell engineering. For the record, CAR T-cell therapy is an FDA-approved treatment that can be utilized for treating hematological malignancies such as multiple myeloma, leukemia, and lymphoma.
The global car t-cell therapy market is expected to grow due to increasing prevalence of cancer, advancements in immunotherapy, rising R&D investments, and growing regulatory approvals for innovative treatments.
According to a study, the global car t-cell therapy market size was worth around USD 609.41 Million in 2024 and is expected to reach USD 6594.52 Million by 2034.
The global car t-cell therapy market is expected to grow at a CAGR of 26.89% during the forecast period.
North America is expected to dominate the car t-cell therapy market over the forecast period.
Leading players in the global car t-cell therapy market include Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc., Johnson & Johnson Services, Inc., JW Therapeutics (Shanghai) Co., Ltd., bluebird bio, Inc., Merck & Co., Inc., Sangamo Therapeutics, Sorrento Therapeutics, Inc., GSK plc., among others.
The report explores crucial aspects of the car t-cell therapy market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
